Association between serum insulin-like growth factor-I levels and thyroid disorders in a population-based study.
Brabant, Georg E
AffiliationInstitute of Community Medicine, University of Greifswald, D-17487 Greifswald, Germany. firstname.lastname@example.org
MetadataShow full item record
AbstractOBJECTIVE: There is current debate on whether serum IGF-I levels are associated with thyroid disorders. The aims of the present study were: 1) to investigate possible associations between serum IGF-I levels and thyroid disorders and 2) to analyze the role of serum IGF binding protein (IGFBP)-3 and TSH levels for these associations. DESIGN: This was a cross-sectional Study of Health in Pomerania. SETTING: The study was conducted in the general population of northeast Germany. Subjects: The study population comprised 3662 subjects (1746 women) without history of thyroid disorders. INTERVENTIONS: No interventions have been performed. MAIN OUTCOME MEASURES: Goiter and thyroid nodules were determined by ultrasound. Serum TSH levels less than 0.25 mIU/liter were considered decreased. RESULTS: Adjusted for major confounders and risk factors for thyroid disorders, subjects with serum IGF-I levels above the upper tertile had higher odds for goiter relative to subjects with serum IGF-I levels below the lower tertile [odds ratio (OR) 1.67; 95% confidence interval (CI) 1.24-2.26 in women; OR 2.04; 95% CI 1.55-2.68 in men]. A similar association was present for thyroid nodules in men (OR 1.64; 95% CI 1.17-2.32) and for decreased serum TSH levels in women (OR 1.65; 95% CI 1.00-2.69). Serum IGFBP-3 levels were not associated with thyroid disorders and did not represent effect modifiers for the association between serum IGF-I levels and the endpoints. CONCLUSIONS: We conclude that high serum IGF-I levels are associated with goiter. Whereas high serum IGF-I levels are also related to thyroid nodules in men, they are related to decreased serum TSH levels in women. Serum IGFBP-3 and TSH levels did not modulate these associations.
CitationAssociation between serum insulin-like growth factor-I levels and thyroid disorders in a population-based study. 2007, 92 (10):4039-45 J. Clin. Endocrinol. Metab.
JournalThe Journal of Clinical Endocrinology and Metabolism
- Insulin-like growth factor-binding protein-3 (IGFBP-3) but not insulin-like growth factor-I (IGF-I) remains elevated in euthyroid TSH-suppressed Graves' disease.
- Authors: Wan Nazaimoon WM, Khalid BA
- Issue date: 1998 Apr
- Association of socioeconomic status with iodine supply and thyroid disorders in northeast Germany.
- Authors: Völzke H, Craesmeyer C, Nauck M, Below H, Kramer A, John U, Baumeister S, Ittermann T
- Issue date: 2013 Mar
- Interactions of thyroid hormones; insulin-like growth factor-1 (IGF-1), IGF binding proteins, and nutritional anthropometric parameters in school children with goiter detected by palpation.
- Authors: Ersoy B, Gunes HS, Uyanik BS, Taneli F, Gunay T
- Issue date: 2009 Oct
- Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.
- Authors: Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA
- Issue date: 2006 Nov
- Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
- Authors: Stattin P, Bylund A, Rinaldi S, Biessy C, Déchaud H, Stenman UH, Egevad L, Riboli E, Hallmans G, Kaaks R
- Issue date: 2000 Dec 6